-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Veracyte, Raises Price Target to $65

Benzinga·06/29/2026 14:06:23
Listen to the news
Guggenheim analyst Subbu Nambi maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $45 to $65.